Literature DB >> 31617584

Borderline anaemia and postoperative outcome in women undergoing major abdominal surgery: a retrospective cohort study.

L F Miles1, T Larsen2, M J Bailey3, K L Burbury4, D A Story1, R Bellomo1.   

Abstract

Pre-operative anaemia is typically diagnosed with a haemoglobin concentration < 120 g.l-1 for women and < 130 g.l-1 for men on the basis of limited evidence. This retrospective cohort study stratified women undergoing elective, major abdominal surgery based on pre-operative haemoglobin concentration: anaemic (< 120 g.l-1 ); borderline anaemic (120-129 g.l-1 ); and non-anaemic (> 130 g.l-1 ). Data from 1554 women were analysed. Women with borderline anaemia had a greater incidence of postoperative complications (55 (16%) vs. 110 (11%); p = 0.026), longer duration of hospital stay (median (IQR [range]) 3 (1-6 [0-69]) days vs. 2 (1-5 [0-80]) days; p = 0.017) and fewer days alive and out of hospital at postoperative day 30 (median (IQR [range]) 27 (23-29 [0-30]) vs. 28 (25-29 [0-30]) days; p = 0.017) compared with non-anaemic women. However, after matched cohort analysis, these outcome differences no longer remained statistically significant. After multivariable adjustment for procedure, Charlson comorbidity index and patient age, a negative relationship between logarithmic pre-operative haemoglobin concentration and duration of stay was found (parameter estimate (standard error) -0.006 (0.003) vs. 0.003 (0.003) for a haemoglobin concentration < 130 g.l-1 vs. > 130 g.l-1 , respectively; p = 0.03); the difference in duration of stay was approximately 50% greater for women with a haemoglobin concentration of 120 g.l-1 compared with those with a haemoglobin concentration of 130 g.l-1 . Although the contribution of borderline anaemia to the incidence of postoperative complications is uncertain, the current diagnostic criteria should be re-assessed.
© 2019 Association of Anaesthetists.

Entities:  

Keywords:  anaemia; digestive system surgical procedures; healthcare; iron deficiency; outcome assessment

Year:  2019        PMID: 31617584     DOI: 10.1111/anae.14870

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

1.  Non-erythropoiesis-stimulating agent, non-iron therapies for the management of anaemia: protocol for a scoping review.

Authors:  Paula Devlin; Amelia Davies; Cory Dugan; Toby Richards; Lachlan F Miles
Journal:  BMJ Open       Date:  2022-04-11       Impact factor: 2.692

2.  Associations between preoperative anaemia and hospital costs following major abdominal surgery: cohort study.

Authors:  J Meyerov; M Louis; D K Lee; L Fletcher; D Banyasz; L F Miles; R Ma; S Tosif; A N Koshy; D A Story; R Bellomo; L Weinberg
Journal:  BJS Open       Date:  2021-03-05

3.  Risk Factors and Patient Outcomes Associated With Immediate Post-operative Anasarca Following Major Abdominal Surgeries: A Prospective Observational Study From 2019 to 2021.

Authors:  Satya P Meena; Metlapalli V Sairam; Ashok K Puranik; Mayank Badkur; Naveen Sharma; Mahendra Lodha; Mahaveer S Rohda; Nikhil Kothari
Journal:  Cureus       Date:  2021-12-23

4.  The Importance of Iron Administration in Correcting Anaemia After Major Surgery.

Authors:  Mirela Tiglis; Cristian Cobilinschi; Liliana Elena Mirea; Alexandru Emil Băetu; Ileana Peride; Tiberiu Paul Neagu; Andrei Niculae; Ionel Alexandru Checherită; Ioana Marina Grintescu
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-08-05

5.  A protocol for prospective observational study to determine if non-anaemic iron deficiency worsens postoperative outcome in adult patients undergoing elective cardiac surgery: the IDOCS study.

Authors:  Lachlan F Miles; Vanessa Pac Soo; Sabine Braat; Stephane Heritier; Kate L Burbury; David A Story
Journal:  Perioper Med (Lond)       Date:  2022-02-08

6.  Intravenous iron therapy for non-anaemic, iron-deficient adults.

Authors:  Lachlan F Miles; Edward Litton; Georgina Imberger; David Story
Journal:  Cochrane Database Syst Rev       Date:  2019-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.